Literature DB >> 900988

Indomethacin does not affect PUVA induced erythema.

F Gschnait, H Pehamberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900988     DOI: 10.1007/bf00562745

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


× No keyword cloud information.
  7 in total

1.  Orally given indomethacin and blood flow response to UVL.

Authors:  R A Greenberg; W H Eaglestein; H Turnier; P V Houdek
Journal:  Arch Dermatol       Date:  1975-03

2.  Phototesting and dosimetry for photochemotherapy.

Authors:  K Wolff; F Gschnait; H Hönigsmann; K Konrad; J A Parrish; T B Fitzpatrick
Journal:  Br J Dermatol       Date:  1977-01       Impact factor: 9.302

3.  Topical indomethacin and sunburn.

Authors:  D S Snyder; W H Eaglstein
Journal:  Br J Dermatol       Date:  1974-01       Impact factor: 9.302

4.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

5.  Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.

Authors:  C M Gruber; A S Ridolfo; R Nickander; W M Mikulaschek
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

6.  The influence of corticosteroids and topical indomethacin on sunburn erythema.

Authors:  K H Kaidbey; A K Kurban
Journal:  J Invest Dermatol       Date:  1976-03       Impact factor: 8.551

7.  The effects of indomethacin on long-wave ultraviolet-induced delayed erythema.

Authors:  W L Morison; B S Paul; J A Parrish
Journal:  J Invest Dermatol       Date:  1977-03       Impact factor: 8.551

  7 in total
  2 in total

1.  Topical indomethacin protects from UVB and UVA irradiation.

Authors:  F Gschnait; T Schwarz; A Seiser
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  Reduction of the erythema response to ultraviolet light by nonsteroidal antiinflammatory agents.

Authors:  E K Edwards; S N Horwitz; P Frost
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.